Articles by Shim Woo-hyun
Shim Woo-hyun
ws@heraldcorp.com-
Lunit's cancer-detecting solution gets EU approval
Lunit, a provider of artificial intelligence-powered cancer solutions, said Monday that it has received approval from the European Union for the commercial launch of its AI-based medical software used in detecting breast cancer. The solution, dubbed Lunit Insight Digital Breast Tomosynthesis, is an AI-based software solution to help identify suspicious lesions with 3D mammograms. “(Lunit) has laid the groundwork for sales in European countries by earning the CE marking in around one month
Technology March 20, 2023
-
Samsung Biologics to invest W2tr for 5th plant
Samsung Biologics said Friday it is investing 2 trillion won ($1.5 billion) to build its fifth production plant as part of efforts to meet market demands and bolster its manufacturing competitiveness. The company announced the plan after an approval from the board of directors earlier in the day. Last year, the company’s revenue exceeded the 3 trillion-won mark for the first time within the bio pharma industry, with its operating profits reaching some 1 trillion won. While its fourth pla
Technology March 17, 2023
-
Hyundai Steel to sell Beijing unit after years of sluggish sales
Hyundai Steel, South Korea’s second-largest steelmaker, said Thursday that it would sell its Beijing unit, Hyundai Steel Beijing Process, after years of sluggish sales compounded by the shrunken market share of Hyundai Motor and Kia cars in China. Hyundai Steel will still keep its Tianjin unit for its business in China, the company added. "(Hyundai Steel) has completed signing a memorandum of understanding with a potential buyer for the Beijing plant. The company will soon engage in
Industry March 16, 2023
-
Posco pledges W4b to compensate wartime forced labor victims
Posco, the country's leading steelmaker, said Wednesday the company will donate 4 billion won ($3 million) to a state-led fund to compensate the victims of forced labor during Japan’s colonial rule of Korea. The 4 billion won is part of the 10 billion won it pledged to contribute to the public fund in 2012. Earlier this month, the Foreign Ministry announced it would collect “voluntary” donations from local companies to the Foundation for Victims of Forced Mobilization, an
Industry March 15, 2023
-
LG Chem signs $200m pediatric vaccine deal with UNICEF
LG Chem said Tuesday that the company signed a deal with the United Nations Children's Fund to supply two pediatric vaccines. Under the deal, LG Chem will supply $100 million worth of its polio vaccine Eupolio and $100 million worth of pentavalent vaccine Eupenta, which works for five different indications including tetanus, diphtheria, pertussis, hepatitis B and Haemophilus influenzae. LG Chem will supply Eupolio for two years from 2024, while the supply of Eupenta will begin this year and
Technology March 14, 2023
-
Amid continued inflation, Korea to review liquor tax system
The government will examine the liquor tax system, which has been propelling recent increases in beer prices amid the persistent inflation. According to the Korean Statistical Information Service’s data on Monday, the price index for beer products at restaurants and outdoor dining establishments has increased to 112.63 in February, up 10.5 percent compared to the same month a year ago. It was higher than the increase of the price index for beer products at discount and convenience stores:
Consumer March 13, 2023
-
Daewoo E&C secures W1tr deal to build power plants in Libya
Daewoo Engineering & Construction announced Friday that the company has secured a deal to build gas-fired power plants in Libya. The construction deal, which Daewoo E&C signed with General Electricity Company of Libya, is worth $790 million (1 trillion won), the company added. Under the deal, Daewoo E&C will build gas-fired power stations in Libya’s Mellitah and Misurata regions. The construction order was made as the Libyan government needed additional power plants to manage i
Industry March 10, 2023
-
[Herald Interview] Pernod Ricard Korea enjoys robust growth amid pandemic-fueled liquor boom
It was not just delivery services or online shopping that thrived in South Korea during the pandemic years. The liquor market, especially for high-end whiskeys and wines, has seen dramatic growth, according to Frantz Hotton, CEO of Pernod Ricardo Korea, the Korean unit of the French wine and spirit giant. Hotton, who took the helm in 2021 when COVID-19 was still rampant across the world, said that people's behavioral changes have had a significant impact on how they consume alcoholic bevera
Consumer March 8, 2023
-
SK Plasma to build $250m blood products plant in Indonesia
SK Plasma, a blood products unit of SK Discovery, announced Wednesday that the company has clinched a deal to build a blood products plant in Indonesia, which is expected to be worth around $250 million. SK Plasma has received final approval from the Indonesian Health Ministry for construction of a plasma fractionation facility, which will produce products like immune globulin and albumin, used for patients with immunodeficiency diseases and hemophilia. The plant will be capable of producing 1 m
Technology March 8, 2023
-
Posco to join recovery projects in typhoon-hit areas
South Korean steel giant Posco said Monday it is teaming up with North Gyeongsang Province for recovery efforts in the areas inflicted by Typhoon Hinnamnor last year. Officials of Posco and the local government signed an agreement in Andong, the provincial capital, earlier in the day, with Posco Vice Chairman Kim Hak-dong in attendance. Under the agreement, Posco will supply resources, including steel products, to be used in construction sites in Pohang and Gyeongju, the hardest-hit areas. Pohan
Industry March 6, 2023
-
[Weekender] Why soju price hikes are causing Koreans so much anguish
Rumors of soju price hikes have stirred public disquiet over the past couple of weeks here, intensifying to the extent that the government decided to intervene in the market. The fuss temporarily ended after Hite Jinro, the country’s largest soju maker, officially announced that it was not planning on any price hikes. “I felt bitter when I heard about possible price hikes in soju, which seemed to hold out well, while everything else is getting more expensive,” said Kim, a 29-
Consumer March 4, 2023
-
Medytox's BTX patent could face invalidation trial in US
A patent regarding Medytox’s botulinum toxin product can be embroiled in another legal dispute as its domestic rival Hugel filed for a patent invalidation in the US, according to industry sources on Friday. The patent, which could be considered for invalidation at the Patent Trial and Appeal Board in the US, concerns a method for isolating Botulinum toxin from solution. Medytox applied for the patent in 2017, and the patent was issued in May last year. Hugel, however, argues that the paten
Technology March 3, 2023
-
Celltrion Group’s retired founder Seo Jung-jin returns to management
Seo Jung-jin, the founder and the honorary chairman of Celltrion Group, will return to management after leaving the company in 2021, Celltrion announced Friday. On Friday, the biopharmaceutical group's key affiliates -- Celltrion Holdings, Celltrion, Celltrion Healthcare, and Celltrion Pharma held separate board meetings and recommended Seo as a candidate for director and co-chairman of the board of directors. Seo’s return will be determined at the four companies’ separate share
Technology March 3, 2023
-
Naver's Webtoon ranked one of world's most innovative platforms
Webtoon, South Korean tech giant Naver’s digital comics platform, has been ranked No. 8 on Fast Company’s list of the World’s 50 Most Innovative Companies of 2023. Fast Company is a monthly American business magazine that publishes an annual ranking of the most innovative companies, this year in 54 different industries and sectors. In the media sector, Webtoon was ranked top, followed by The New York Times. Fast Company said, “Webtoon pioneered a new way to experience dig
Technology March 3, 2023
-
GC acquires Catalyst's orphan hematology disorder pipeline
GC Biopharma announced on Tuesday that it has signed an asset purchase agreement with US drug developer Catalyst Biosciences to acquire its orphan hematology disorder treatment candidates. Under the agreement, GC Biopharma will acquire three drug candidates including Marzeptacog alfa (MarzAA), a rare bleeding disorder treatment candidate, which is being tested in a phase 3 global clinical trial. With the latest agreement, GC Biopharma aims to launch a first-in-class novel drug in global markets,
Technology Feb. 28, 2023
Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Seoul to host winter festival from Dec. 13
-
4
Blackpink's solo journeys: Complementary paths, not competition
-
5
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
6
Korean Air offers special flights for mileage users
-
7
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
8
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
9
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
-
10
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says